Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 5Phase NA 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 653Ovarian Neoplasms 441Endometrial Neoplasms 290Breast Neoplasms 179Uterine Cervical Dysplasia 133Neoplasms 86Carcinoma, Ovarian Epithelial 80Papillomavirus Infections 69Prostatic Neoplasms 67Uterine Neoplasms 66Vulvar Neoplasms 64Colorectal Neoplasms 59Fallopian Tube Neoplasms 54Colonic Neoplasms 47Peritoneal Neoplasms 45Pancreatic Neoplasms 45Lung Neoplasms 45Urinary Bladder Neoplasms 39Vaginal Neoplasms 34Gynecologic Cancer 33Stomach Neoplasms 32Head and Neck Neoplasms 31Hereditary Breast and Ovarian Cancer Syndrome 27Sarcoma 26Rectal Neoplasms 26Pelvic Neoplasms 26Melanoma 25Esophageal Neoplasms 25Recurrence 24Ovarian Cysts 24

Interventions

apatinib 1Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Ovarian Cancer Recurrent × Gynecologic × Clear all
NCT06102707 2023-10-26

The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients

Qilu Hospital of Shandong University

Phase NA Not yet recruiting
50 enrolled
Gynecologic

Ovarian Cancer Recurrent

NCT03717610 2021-10-08

Hyperthermic Intraperitoneal Chemotherapy for Treatment of Relapsed Ovarian Cancer

Uppsala University Hospital

Phase NA Unknown
10 enrolled
Gynecologic

Ovarian Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡